Tabula Rasa HealthCare, Inc. TRHC
Set alert
At close · Nov 2
52-week range unavailable
- Open
- 10.41
- Prev close
- 10.50
- Mkt cap
- 284.03M
- Vol
- 1.31M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.41
- High
- 10.50
- Forward P/E
- 42.00
- Beta
- 1.57
- Short ratio
- 3.29
- Inst. own
- 70.70%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 2, 2023
- 50-d avg
- 10.36
- 200-d avg
- 7.69
- 1y target
- 10.50
2Y chart
Events in this range
- Jun 21, 2022Rating: Piper Sandler · — → Neutral
- Aug 4, 2022Earnings: —; estimate 0.01; surprise —%
- Aug 17, 2022Rating: Piper Sandler · — → Neutral
- Nov 3, 2022Earnings: —; estimate -0.03; surprise —%
- Mar 6, 2023Earnings: —; estimate 0.05; surprise —%
- May 8, 2023Earnings: —; estimate -0.15; surprise —%
- May 9, 2023Rating: SVB Leerink · Market Perform → Outperform
- Aug 7, 2023Earnings: —; estimate -0.14; surprise —%
- Nov 2, 2023Earnings: —; estimate -0.02; surprise —%
Signals (60)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 6, 2023 | 2 years ago |
| RSI: Overbought | Nov 2, 2023 | 2 years ago |
| RSI: Overbought | Oct 31, 2023 | 3 years ago |
| RSI: Overbought | Oct 2, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 24, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 7, 2023 | 3 years ago |
| RSI: Overbought | Aug 7, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 19, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 17, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 14, 2023 | 3 years ago |
| RSI: Overbought | Jun 30, 2023 | 3 years ago |
| RSI: Overbought | Jun 16, 2023 | 3 years ago |
| RSI: Overbought | Jun 9, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 6, 2023 | 3 years ago |
| SMA: Bearish | May 24, 2023 | 3 years ago |
| MACD: Sell Signal | May 24, 2023 | 3 years ago |
| SMA: Bullish | May 9, 2023 | 3 years ago |
| SMA: Bearish | May 4, 2023 | 3 years ago |
| SMA: Bullish | May 3, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 3, 2023 | 3 years ago |
| SMA: Bearish | Mar 10, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 2, 2023 | 3 years ago |
| RSI: Overbought | Jan 19, 2023 | 3 years ago |
| RSI: Overbought | Jan 17, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 10, 2023 | 3 years ago |
| MACD: Sell Signal | Jan 5, 2023 | 3 years ago |
| RSI: Overbought | Dec 30, 2022 | 3 years ago |
| SMA: Bullish | Nov 30, 2022 | 3 years ago |
| SMA: Bullish | Nov 30, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 10, 2022 | 3 years ago |
| RSI: Oversold | Nov 9, 2022 | 3 years ago |
| RSI: Oversold | Oct 21, 2022 | 4 years ago |
| SMA: Bearish | Oct 3, 2022 | 4 years ago |
| SMA: Bullish | Sep 30, 2022 | 4 years ago |
| SMA: Bearish | Sep 22, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 19, 2022 | 4 years ago |
| RSI: Overbought | Aug 12, 2022 | 4 years ago |
| RSI: Overbought | Jul 28, 2022 | 4 years ago |
| RSI: Overbought | Jul 25, 2022 | 4 years ago |
| SMA: Bullish | Jul 21, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 18, 2022 | 4 years ago |
| MACD: Sell Signal | Jun 30, 2022 | 4 years ago |
| MACD: Buy Signal | Jun 23, 2022 | 4 years ago |
| MACD: Sell Signal | Jun 16, 2022 | 4 years ago |
| MACD: Buy Signal | May 25, 2022 | 4 years ago |
| RSI: Oversold | May 20, 2022 | 4 years ago |
| MACD: Sell Signal | May 18, 2022 | 4 years ago |
| MACD: Buy Signal | May 6, 2022 | 4 years ago |
| MACD: Sell Signal | Apr 29, 2022 | 4 years ago |
| RSI: Oversold | Apr 29, 2022 | 4 years ago |
| MACD: Buy Signal | Apr 25, 2022 | 4 years ago |
| MACD: Sell Signal | Apr 14, 2022 | 4 years ago |
| RSI: Oversold | Mar 16, 2022 | 4 years ago |
| RSI: Oversold | Mar 14, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 3, 2022 | 4 years ago |
| RSI: Oversold | Feb 16, 2022 | 4 years ago |
| RSI: Oversold | Feb 14, 2022 | 4 years ago |
| RSI: Oversold | Feb 2, 2022 | 4 years ago |
| SMA: Bearish | Jan 24, 2022 | 4 years ago |
| MACD: Sell Signal | Jan 14, 2022 | 4 years ago |
Key statistics
- Market cap
- 284.03M
- Enterprise value
- 548.09M
- Trailing P/E
- 0.00
- Forward P/E
- 42.00
- PEG ratio
- -8.66
- Price / sales
- 0.84
- Price / book
- 0.00
- EPS (TTM)
- -2.46
- Beta
- 1.57
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -28.23%
- Revenue (TTM)
- 338.12M
- Revenue growth
- 24.00%
- Free cash flow
- 147.21M
- Total cash
- 62.81M
- Total debt
- 341.97M
- Return on equity
- 0.00%
- Shares outstanding
- 27.05M
- Short % of float
- 3.90%
- 50-day average
- 10.36
- 200-day average
- 7.69
Analyst view
Consensus: hold
- Strong buy2
- Buy2
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 2, 2023
Expected Nov 2, 2023. Consensus EPS estimate -0.02.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 2, 2023 | Sep 1, 2023 | -0.02 | — | — | — |
| Aug 7, 2023 | Jun 1, 2023 | -0.14 | — | — | — |
| May 8, 2023 | Mar 1, 2023 | -0.15 | — | — | — |
| Mar 6, 2023 | Dec 1, 2022 | 0.05 | — | — | — |
| Nov 3, 2022 | Sep 1, 2022 | -0.03 | — | — | — |
| Aug 4, 2022 | Jun 1, 2022 | 0.01 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 6, 2023 | William Blair | down | Outperform | Market Perform |
| May 9, 2023 | SVB Leerink | up | Market Perform | Outperform |
| Nov 6, 2022 | Piper Sandler | main | — | Neutral |
| Aug 17, 2022 | Piper Sandler | main | — | Neutral |
| Aug 7, 2022 | SVB Leerink | main | — | Market Perform |
| Jun 21, 2022 | Piper Sandler | main | — | Neutral |
About Tabula Rasa HealthCare, Inc.
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise Risk Score, a medication risk stratification technology for identification of patients in need of clinical intervention. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third-party administrator services. As of December 31, 2022, it served approximately 150 healthcare organizations. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey. As of November 3, 2023, Tabula Rasa HealthCare, Inc. operates as a subsidiary of Exact Care Pharmacy, LLC.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- tabularasahealthcare.com
News
- ExactCare and Tabula Rasa HealthCare Rebrand Combined Organization as AnewHealth
- ExactCare and Tabula Rasa HealthCare Business Combination Closes, Creating a Leading, Independent Value-Based Pharmacy Management Company for Patients with the Most Complex Needs
- Tabula Rasa HealthCare Stockholders Approve Acquisition by Nautic Partners
- TABULA RASA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tabula Rasa HealthCare, Inc. - TRHC
- TABULA RASA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tabula Rasa HealthCare, Inc. - TRHC
- TABULA RASA SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of $10.50 Per Share Buyout Agreement - TRHC
- Why Shares of Tabula Rasa HealthCare Are Soaring Monday
- Compared to Estimates, Tabula Rasa Healthcare (TRHC) Q2 Earnings: A Look at Key Metrics
- Tabula Rasa Healthcare (TRHC) Q2 Earnings and Revenues Surpass Estimates
- TRHC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Tabula Rasa Healthcare, Inc. Is Fair to Shareholders
Your note
Sign in to keep a note on TRHC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ADAMS BRIAN W. | Chief Executive Officer | Conversion of Exercise of derivative security | Jun 27, 2023 | 474,603 |
| BECKWITH SAMIRA K. | Director | Stock Award(Grant) | Jun 8, 2023 | 88,042 |
| GREENHALGH MICHAEL | Chief Operating Officer | Conversion of Exercise of derivative security | Jun 27, 2023 | 365,109 |
| HELLING DENNIS K. | Director | Stock Award(Grant) | Jun 8, 2023 | 112,109 |
| INDABA CAPITAL MANAGEMENT L P | Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jun 8, 2023 | 0 |
| MITCHELL RONALD PAUL | Director | Stock Award(Grant) | Jun 8, 2023 | 79,332 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Indaba Capital Management, L.P. | 24.11% | 6,521,578 | 53.80M | Jun 29, 2023 |
| Wasatch Advisors LP | 4.25% | 1,148,861 | 9.48M | Jun 29, 2023 |
| Baillie Gifford and Company | 3.07% | 831,278 | 6.86M | Jun 29, 2023 |
| Vanguard Group Inc | 3.06% | 826,676 | 6.82M | Jun 29, 2023 |
| Kent Lake Capital, LLC | 2.22% | 599,691 | 4.95M | Jun 29, 2023 |
| Blackrock Inc. | 1.77% | 478,438 | 3.95M | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Wasatch Microcap Fund | 4.23% | 1,143,920 | 9.44M | Jun 29, 2023 |
| Vanguard Total Stock Market Index Fund | 1.60% | 433,909 | 3.58M | Jun 29, 2023 |
| Invesco ETF Tr II-Invesco DWA Small Cap Momentum ETF | 1.34% | 362,648 | 3.72M | Aug 30, 2023 |
| Vanguard Extended Market Index Fund | 1.29% | 348,345 | 2.87M | Jun 29, 2023 |
| Federated Hermes MDT Mid Cap Growth Fund | 0.80% | 216,627 | 1.74M | Jul 30, 2023 |
| Paradigm Micro Cap Fund | 0.70% | 188,100 | 1.55M | Jun 29, 2023 |